Table 5.
Site | Treatment | Number of Replicates | Mean Chl. a (μg cm-2) | Standard Deviation (μg cm-2) | SNK Group (α = 0.05) | ||
NB-03 | C | 8 | 0.49 | 0.24 | C | ||
N | 9 | 0.86 | 0.35 | C | |||
N+P | 9 | 4.55 | 1.92 | A | |||
P1 | 7 | 0.67 | 0.17 | C | |||
P2 | 7 | 0.71 | 0.24 | C | |||
P3 | 9 | 0.67 | 0.24 | C | |||
P4 | 9 | 0.85 | 0.42 | C | |||
P5 | 9 | 0.79 | 0.19 | C | |||
NB-05 | C | 9 | 0.99 | 0.26 | C | ||
N | 9 | 1.02 | 0.42 | C | |||
N+P | 8 | 2.15 | 0.50 | B | |||
P1 | 9 | 1.08 | 0.34 | C | |||
P2 | 9 | 1.13 | 0.37 | C | |||
P3 | 9 | 1.17 | 0.36 | C | |||
P4 | 8 | 0.89 | 0.34 | C | |||
P5 | 9 | 1.99 | 0.59 | B |